Silver Book Fact

~3/4 of all HAIs occur outside of ICU

Nearly 3/4 of all hospital-acquired HAIs occur outside of the intensive care unit (ICU).

Klevens, R. Monina, Jonathan R. Edwards, Chesley L. Richards, Jr., Teresa C. Horan, Robert P. Gaynes, Daniel A. Pollock, and Denise M. Cardo. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Public Health Reports. 2007; 122(2): 160-6. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820440/

Reference

Title
Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002
Publication
Public Health Reports
Publication Date
2007
Authors
Klevens, R. Monina, Jonathan R. Edwards, Chesley L. Richards, Jr., Teresa C. Horan, Robert P. Gaynes, Daniel A. Pollock, and Denise M. Cardo
Volume & Issue
Volume 122, Issue 2
Pages
160-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • Drug-resistant MRSA expensive to treat
    As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.  
  • Most common principal diagnoses for hospitalized patients with HAIs
    The most common principal diagnoses for hospitalized patients with HAIs are: Septicemia 11.8% Adult respiratory failure 5.9% Complications from surgical or medical care 4.1%  
  • HAIs cost patients additional $43,000 per hospital stay
    Patients with HAIs cost, on average, $43,000 more per hospital stay than those without an infection ($52,096 vs. $9,377).  
  • Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually
    Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.  
  • Dramatic increase of antibiotic resistance between 1981 and 2001
    Increase in antibiotic resistance over 20 year period